Martens Rachel Yap
SEC insider (Form 3/4/5 filer). CIK 0002071589. SVP, Partnerships & Corp Strat at LEXICON PHARMACEUTICALS, INC. (LXRX). 4 reported Form 4/5 transactions since Sep 2024; latest on Feb 28, 2026. Located in THE WOODLANDS, TX.
Companies Martens Rachel Yap has filed insider reports for
- LEXICON PHARMACEUTICALS, INC. (LXRX): Officer, SVP, Partnerships & Corp Strat
Martens Rachel Yap
CIK: 0002071589
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LEXICON PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
ExerciseDirect67.1K shares- - Feb 28, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
Tax PaymentDirect35.8K shares at avg. $1.47$53K - Feb 12, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectRestricted Stock Units
193.7K shares- - Feb 12, 2026LXRX
LEXICON PHARMACEUTICALS, INC.
AwardDirectStock Option (Right to Buy)
290.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Exercise | 67,090 | - | $0 | Direct |
| Feb 28, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Tax Payment | 35,826 | $1.47 | $52,664 | Direct |
| Feb 12, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Restricted Stock Units | 193,740 | - | - | Direct |
| Feb 12, 2026 | LXRX LEXICON PHARMACEUTICALS, INC. | Award Stock Option (Right to Buy) | 290,620 | - | - | Direct |
1-4 of 4 transactions